BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 16475209)

  • 21. Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma.
    Cai JY; Tang YJ; Jiang LM; Pan C; Chen J; Tang JY
    Pediatr Blood Cancer; 2007 Dec; 49(7):952-7. PubMed ID: 17514736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroblastoma--a surgical perspective.
    Losty P; Quinn F; Breatnach F; O'Meara A; Fitzgerald RJ
    Eur J Surg Oncol; 1993 Feb; 19(1):33-6. PubMed ID: 8436238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and outcome of thoracic neuroblastoma.
    Häberle B; Hero B; Berthold F; von Schweinitz D
    Eur J Pediatr Surg; 2002 Jun; 12(3):145-50. PubMed ID: 12101494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatopathy in patients with stage 4S neuroblastoma].
    Claviez A; Hero B; Schneppenheim R; Berthold F
    Klin Padiatr; 1996; 208(4):221-8. PubMed ID: 8926687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroblastoma in Turkish children: experience of a single center.
    Aydn GB; Kutluk MT; Yalçn B; Büyükpamukçu M; Kale G; Varan A; Akyüz C; Senocak ME; Büyükpamukçu N
    J Pediatr Hematol Oncol; 2009 Jul; 31(7):471-80. PubMed ID: 19564739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonrhabdomyosarcoma soft tissue sarcomas in children: is age at diagnosis an important variable?
    Hayes-Jordan AA; Spunt SL; Poquette CA; Cain AM; Rao BN; Pappo AS; Shochat SJ
    J Pediatr Surg; 2000 Jun; 35(6):948-53; discussion 953-4. PubMed ID: 10873042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patients.
    Kushner BH; Kramer K; LaQuaglia MP; Modak S; Cheung NK
    Pediatr Blood Cancer; 2006 Mar; 46(3):278-84. PubMed ID: 16124002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhabdomyosarcoma in adolescents: a report from the AIEOP Soft Tissue Sarcoma Committee.
    Bisogno G; Compostella A; Ferrari A; Pastore G; Cecchetto G; Garaventa A; Indolfi P; De Sio L; Carli M
    Cancer; 2012 Feb; 118(3):821-7. PubMed ID: 21751206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.
    London WB; Castleberry RP; Matthay KK; Look AT; Seeger RC; Shimada H; Thorner P; Brodeur G; Maris JM; Reynolds CP; Cohn SL
    J Clin Oncol; 2005 Sep; 23(27):6459-65. PubMed ID: 16116153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern and outcome of neuroblastoma. A 10 year study.
    Kusumakumary P; Ajithkumar TV; Ratheesan K; Chellam VG; Nair MK
    Indian Pediatr; 1998 Mar; 35(3):223-9. PubMed ID: 9707875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma.
    Mazzoleni S; Bisogno G; Garaventa A; Cecchetto G; Ferrari A; Sotti G; Donfrancesco A; Madon E; Casula L; Carli M;
    Cancer; 2005 Jul; 104(1):183-90. PubMed ID: 15895378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma.
    Fukuda M; Nozaki C; Ishiguro Y; Horibe K
    Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss in chromosome 11q identifies tumors with increased risk for metastatic relapses in localized and 4S neuroblastoma.
    Spitz R; Hero B; Simon T; Berthold F
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3368-73. PubMed ID: 16740759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
    Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
    Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroblastoma in adults and adolescents: an indolent course with poor survival.
    Franks LM; Bollen A; Seeger RC; Stram DO; Matthay KK
    Cancer; 1997 May; 79(10):2028-35. PubMed ID: 9149032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival analysis of clinical, pathologic, and genetic features in neuroblastoma presenting as locoregional disease.
    Mora J; Cheung NK; Chen L; Qin J; Gerald W
    Cancer; 2001 Jan; 91(2):435-42. PubMed ID: 11180092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease.
    Simon T; Hero B; Bongartz R; Schmidt M; Müller RP; Berthold F
    Strahlenther Onkol; 2006 Jul; 182(7):389-94. PubMed ID: 16826357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term results of therapy for stage C neuroblastoma.
    Halperin EC
    J Surg Oncol; 1996 Nov; 63(3):172-8. PubMed ID: 8944061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma.
    Kuroda T; Morikawa N; Matsuoka K; Fujino A; Honna T; Nakagawa A; Kumagai M; Masaki H; Saeki M
    J Pediatr Surg; 2008 Dec; 43(12):2182-5. PubMed ID: 19040931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.